BlinkLab Says European ADHD Study Completes Participant Recruitment, Shares Fall 3%

MT Newswires Live
06/26

BlinkLab (ASX:BB1) said its European attention-deficit/hyperactivity disorder (ADHD) study, being conducted in collaboration with Mental Care Group, completed participant recruitment and the firm's neurometric data collection, enrolling 375 children, according to a Friday Australian bourse filing.

The study is designed to evaluate the firm's objective neurometric measures against comprehensive clinical ADHD diagnoses. The clinical diagnostic reference dataset, completed in the final stage of the study, will be used to evaluate the neurometric measures against diagnostic standards for ADHD.

Its shares fell 3% in recent trading on Friday.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10